Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
1.735
-0.035 (-1.98%)
Sep 11, 2026, 1:38 PM EDT - Market open
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $629.15 million as of September 11, 2026. Its market cap has decreased by -48.30% in one year.
Market Cap
629.15M
Enterprise Value
641.10M
1-Year Change
-48.30%
Ranking
Category
Stock Price
$1.74
ChartMarket Cap Chart
Since the IPO on November 4, 2021, Evotec SE's market cap has decreased from $9.19B to $629.15M, a decrease of -93.15%. That is a compound annual growth rate of -42.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 629.15M | -44.66% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | -8.26% |
| Nov 4, 2021 | 9.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pacira BioSciences | 1.01B |
| Amphastar Pharmaceuticals | 991.98M |
| Glass House Brands | 757.71M |
| Collegium Pharmaceutical | 745.20M |
| Ironwood Pharmaceuticals | 653.52M |
| Aquestive Therapeutics | 601.20M |
| Tilray Brands | 558.93M |
| Evolus | 524.44M |